Inscription Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $516K | Sell |
21,300
-16,884
| -44% | -$409K | 0.07% | 198 |
|
|
2025
Q1 | $1.06M | Buy |
+38,184
| New | +$1.06M | 0.17% | 97 |
|
|
2024
Q3 | $926K | Sell |
32,013
-4,383
| -12% | -$127K | 0.14% | 117 |
|
|
2024
Q2 | $1.02M | Sell |
36,396
-1,788
| -5% | -$50K | 0.16% | 102 |
|
|
2024
Q1 | $1.06M | Buy |
38,184
+21,875
| +134% | +$607K | 0.17% | 97 |
|
|
2023
Q4 | $470K | Buy |
16,309
+1,914
| +13% | +$55.1K | 0.13% | 123 |
|
|
2023
Q3 | $477K | Sell |
14,395
-938
| -6% | -$31.1K | 0.16% | 103 |
|
|
2023
Q2 | $562K | Buy |
15,333
+135
| +0.9% | +$4.95K | 0.17% | 94 |
|
|
2023
Q1 | $620K | Sell |
15,198
-4,744
| -24% | -$194K | 0.16% | 102 |
|
|
2022
Q4 | $1.02M | Buy |
19,942
+300
| +2% | +$15.4K | 0.35% | 66 |
|
|
2022
Q3 | $860K | Sell |
19,642
-24,844
| -56% | -$1.09M | 0.24% | 72 |
|
|
2022
Q2 | $2.33M | Buy |
44,486
+25,334
| +132% | +$1.33M | 0.42% | 53 |
|
|
2022
Q1 | $992K | Sell |
19,152
-200
| -1% | -$10.4K | 0.28% | 75 |
|
|
2021
Q4 | $1.14M | Buy |
19,352
+7,910
| +69% | +$467K | 0.31% | 73 |
|
|
2021
Q3 | $492K | Sell |
11,442
-402,135
| -97% | -$17.3M | 0.15% | 124 |
|
|
2021
Q2 | $16.2M | Buy |
413,577
+401,991
| +3,470% | +$15.7M | 1.84% | 10 |
|
|
2021
Q1 | $420K | Buy |
11,586
+3,907
| +51% | +$142K | 0.14% | 124 |
|
|
2020
Q4 | $283K | Sell |
7,679
-145
| -2% | -$5.34K | 0.11% | 141 |
|
|
2020
Q3 | $272K | Buy |
+7,824
| New | +$272K | 0.12% | 130 |
|
|
2020
Q2 | – | Sell |
-6,875
| Closed | -$213K | – | 145 |
|
|
2020
Q1 | $213K | Buy |
+6,875
| New | +$213K | 0.14% | 114 |
|
|
2019
Q2 | – | Sell |
-1,054
| Closed | -$42K | – | 205 |
|
|
2019
Q1 | $42K | Buy |
+1,054
| New | +$42K | 0.02% | 195 |
|